Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2010 May 14;19(4):290–293. doi: 10.1016/j.jstrokecerebrovasdis.2009.06.001

Table 1.

Exclusion criteria in ECASS III applied to the NINDS sample

Placebo t-PA
NINDS overall sample (n) 312 312
Excluded patients:
Age >80 years 29 40
Baseline NIHSS >25 23 29
Stroke involving >1/3 MCA 43 34
Known diabetic with prior stroke 25 26
Any heparin use 6 5
Final sample size (n) 199 200

Some patient were excluded for more than one reason